DC260126: a small-molecule antagonist of GPR40 that protects against pancreatic β-Cells dysfunction in db/db mice.
G protein-coupled receptor 40 (GPR40) mediates both acute and chronic effects of free fatty acids (FFAs) on insulin secretion. However, it remains controversial whether inhibition of GPR40 would be beneficial in prevention of type 2 diabetes. This study is designed to evaluate the potential effects...
Guardado en:
Autores principales: | Peng Sun, Ting Wang, Yuren Zhou, Hong Liu, Hualiang Jiang, Weiliang Zhu, Heyao Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a53542f5ffd74f059489f804e6d9ee9a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Valsartan alleviates the blood–brain barrier dysfunction in db/db diabetic mice
por: Longxue Cai, et al.
Publicado: (2021) -
Early combination therapy of empagliflozin and linagliptin exerts beneficial effects on pancreatic β cells in diabetic db/db mice
por: Yoshiro Fushimi, et al.
Publicado: (2021) -
Artemether Regulates Metaflammation to Improve Glycolipid Metabolism in db/db Mice
por: Fu W, et al.
Publicado: (2020) -
Effect of the sodium–glucose cotransporter 2 inhibitor luseogliflozin on pancreatic beta cell mass in db/db mice of different ages
por: Kiyohiko Takahashi, et al.
Publicado: (2018) -
Vascular dysfunction in obese diabetic db/db mice involves the interplay between aldosterone/mineralocorticoid receptor and Rho kinase signaling
por: Aurelie Nguyen Dinh Cat, et al.
Publicado: (2018)